TESTIMONIALS
推薦の声
推荐信
Testimoni
Here is What Some of the Leaders of the Field Have to Say About This Meeting:
“This is a valuable platform to showcase the latest innovations in liquid biopsy testing for accurate and more accessible precision medicine and diagnostic solutions in APAC.” Min Qing, Scientific Director, Johnson & Johnson
“This is a great platform to get the CDx knowledge, as well as opportunities to network.” Mike Ye, Head-CDx & Biomarker, CStone Pharma
“I believe that participating in discussions where companies share their experiences will have a positive impact on the consideration of future strategies for our own.” Tsuyoshi Morishita, Associate Director, Global Biomarker, Kyowa Kirin
“The conference provides a valuable networking opportunity for professionals in the industries, allowing them to exchange insights and promote industry development, especially in emerging markets.” Li Feng, Director, Harbour BioMed
“I am excited to share my insights at this meeting. This summit presents a unique opportunity to discuss the latest advancements in companion diagnostics and liquid biopsy technologies, which are revolutionizing personalized medicine. I look forward to engaging with fellow experts to explore innovative strategies that can accelerate the development and implementation of these cutting-edge tools, ultimately improving patient outcomes across the region. Together, we can drive forward the future of precision healthcare.” Sharon Liang, Executive Director, Head, Precision Medicine & Digital Health, Bristol Myers Squibb